Mahathir Bayena

Performance Shipping (NASDAQ:PSHG) reported a 59% increase in first-quarter revenue for 2026, driven by a larger operational fleet and stronger charter rates that accelerated the company's operating cash generation.

Genprex (NASDAQ:GNPX) announced the official abstract publication of positive clinical biomarker data for its lead oncology candidate, Reqorsa gene therapy (quaratusugene ozeplasmid), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Cogent Communications (NASDAQ:CCOI) entered into a definitive purchase and sale agreement to divest a portfolio of 10 data center facilities to global infrastructure investment manager I Squared Capital for $225 million in cash.

Champion Homes (NYSE:SKY) reported higher net sales for both the fourth quarter and full fiscal year 2026, leveraging steady average selling prices to counter macroeconomic housing headwinds while refreshing its capital return program.

Editas Medicine (NASDAQ:EDIT) presented preclinical data for its lead in vivo gene-editing candidate, EDIT-401, demonstrating that a single dose slashed three key drivers of cardiovascular disease by 90% or more in non-human primates.

Senstar Technologies (NASDAQ:SNT) reported a minor revenue decline and swung to an operating loss for the first quarter, hampered by elongated customer procurement cycles and project delays within its core U.S. government market.

MINISO Group Holding (NYSE:MNSO) reported a 28.5% increase in revenue for the March quarter, matching capital market expectations as the value lifestyle retailer expanded its domestic and international store networks.

CleanSpace (ASX:CSX) has issued a downbeat trading update for the 2026 financial year.

Osteopore (ASX:OSX) secured a major regulatory breakthrough, obtaining approval from the Hainan Medical Products Administration.

Bitcoin has entered a higher-risk trading environment as persistent outflows from US spot Bitcoin ETFs fuel concerns over growing institutional selling pressure.